ACROMEGALY

Clinical Endocrinology

Volumn 26, Issue 4, 1987, Pages 481-512

  NABARRO, J D N ^a  

^a MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; PROTIRELIN;

ACROMEGALY; DIAGNOSIS; DRUG BLOOD LEVEL; DRUG EFFICACY; ENDOCRINE SYSTEM; GIGANTISM; HEREDITY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KYPHOSCOLIOSIS; LIFE EXPECTANCY; PRIORITY JOURNAL; REVIEW; SURVEY; TREATMENT;

ACROMEGALY; ADOLESCENT; ADULT; AGED; FEMALE; HUMAN; MALE; MIDDLE AGE; TIME FACTORS;

EID: 0023146458     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.1987.tb00805.x     Document Type: Review

References (102)

1. Epidemiology of acromegaly in the Newcastle region
2. Transsphenoidal microsurgery in the treatment of acromegaly and gigantism
3. Clinical use of pre‐ and post‐surgical evaluation of GH responses in acromegaly
4. Prevalence of ischemic heart disease and associations with serum lipoproteins in subjects aged 45 to 64 years. The Speedwell study
5. Rarity of diabetic retinopathy in patients with acromegaly
6. Familial multiple endocrine adenoma–peptic ulcer complex
7. Hypertension in acromegaly
8. The medical management of acromegaly
9. Acromegalic arthropathy
10. Manifestations cardio‐vasculaires de ľ acromégalie
11. Acanthosis nigricans and pituitary tumours
12. Hyperparathyroidism
13. Endoscopic findings in sleep apnoea associated with acromegaly
14. Hyperthyroidism and acromegaly due to a thyrotropin and growth hormone‐secreting pituitary tumour
15. Evaluation of acromegaly by radioimmunoassay of somatomedin‐C
16. Acromegaly and diabetes mellitus
17. The heart in acromegaly: an echocardiographic study
18. The pathological findings in four autopsied cases of acromegaly with a discussion of their significance
19. Studies in acromegaly III. The anamnesis and symptomatology in one hundred cases
20. Acute massive infarction of pituitary adenomas
21. Regression of acromegaly following pituitary apoplexy
22. Pulmonary function in acromegaly
23. The physiology and chemistry of growth hormone
24. How effective is external pituitary irradiation for growth hormone‐secreting pituitary tumours
25. Incidence and significance of hyperprolactinaemia in women with amenorrhoea
26. Prolactin concentrations in patients with acromegaly: clinical significance and response to surgery
27. Studies on prolactin in man
28. Acromegaly: a review of 100 cases
29. Fixation of the vocal cords in acromegaly
30. Histologic, ultrastructural and hormonal characterisation of a pituitary tumour secreting both HGH and prolactin
31. The arterial pressure in the general population
32. Acromegaly
33. The spectrum of pituitary growth hormone responses to pharmacological stimuli in acromegaly
34. Transsphenoidal microsurgical treatment of pituitary tumours
35. Lung function in acromegaly
36. Clinical features of acromegaly and response to cryohypophysectomy
37. Recovery from paradoxical growth hormone responses in acromegaly after transsphenoidal selective adenomectomy
38. A radio‐immunoelectrophoretic assay for human growth hormone
39. Increase in serum growth hormone concentration following thyrotrophinreleasing hormone injection in patients with acromegaly or gigantism
40. Acromegaly and colon cancer
41. Use of activated charcoal in the radio‐immunoassay of growth hormone in plasma
42. Changes in plasma growth hormone levels after surgical treatment of acromegaly
43. Pathophysiology and control of prolactin secretion in patients with pituitary and hypothalamic disease
44. The acromegaly syndrome relation between clinical features, growth hormone values and radiological characteristics of the pituitary tumours
45. Circadian regulation of growth hormone secretion after treatment of acromegaly
46. Pituitary adenomas in acromegalic patients: an immunohistochemical and endocrinological study with special reference to prolactin‐secreting adenoma
47. Clinical and laboratory study of acromegaly: assessment before and one year after treatment
48. Acromegaly and hypertension: role of the renin‐angiotensin‐aldosterone system
49. British Diabetic Association: new criteria and classification for diabetes mellitus (letter)
50. The articular and other limb changes in acromegaly
51. Airway difficulties associated with anaesthesia in acromegaly
52. Colon polyps in patients with acromegaly
53. Interrelationships between tumour size, age, plasma, growth hormone and incidence of extrasellar extension in acromegalic patients
54. Proton beam therapy of acromegaly: a 20 year experience
55. Chromophobe pituitary adenoma with acromegaly and TSH‐induced hyperthyroidism associated with parathyroid adenoma
56. Thyroid function in acromegaly before and after transsphenoidal hypophysectomy followed by cryoapplication
57. Hyperthyroidism and acromegaly caused by a pituitary TSH‐ and GH‐secreting tumour
58. Different responses of growth hormone secretion to guanfacine, bromocriptine and thyrotrophin‐releasing hormone in acromegalic patients with pure growth hormone (GH)‐containing and mixed GH/prolactin‐containing pituitary adenomas
59. Hypothalamic hypopituitarism after pituitary apoplexy in acromegaly
60. Successful treatment of acromegaly: metabolic and clinical studies in 145 patients
61. The pathogenesis of acromegaly
62. Pathology of the heart in acromegaly: anatomic findings in 27 autopsied cases
63. Acromegaly
64. Growth hormone (GH)‐releasing activity of TRH and GH‐lowering effects of dopaminergic drugs in acromegaly
65. Acromegaly and cardiovascular disorders
66. Hemorrhage, necrosis and apoplexy in pituitary adenomas
67. Concomitance of multiple adenomas of the parathyroids and pancreatic islets with tumour in the pituitary
68. Co‐existing primary empty sella syndrome and acromegaly
69. Vigorous exercise in leisure time: protection against coronary heart disease
70. Papilledema in two patients with acromegaly and intrasellar pituitary tumours
71. Occurrence of cancer in acromegaly and hypopituitarism
72. Acromegaly, hyperparathyroidism and pheochromocytoma in the same patient
73. Management of acromegaly
74. Pituitary surgery for endocrine disorders
75. Pituitary prolactinomas
76. Pituitary tumours–the physician's view
77. Median neuropathy (carpal tunnel syndrome) in acromegaly
78. Sleep apnoea in acromegaly
79. Cardiorespiratory disease and diabetes among middle‐aged male civil servants
80. The importance of insulin‐like growth factor (somatomedin) measurements in the diagnosis and surveillance of acromegaly
81. Long‐term results of transsphenoidal pituitary microsurgery in 60 acromegalic patients
82. Acromegaly with sleep disturbances relieved by yttrium‐90 pituitary implantation
83. Critical study of the growth hormone response to dynamic tests and the insulin growth factor assay in acromegaly after microsurgery
84. Abnormalities in the release of TSH in response to thyrotrophin releasing hormone (TRH) in patients with disorders of the pituitary, hypothalamus and basal ganglia
85. Ectopic secretion of a growth hormone‐releasing factor
86. Acromegaly: Biochemical assessment of cure after long term follow up of transsphenoidal selective adenomectomy
87. An investigation into the pathogenesis of hypertension in acromegaly
88. Changes of carbohydrate tolerance in acromegaly with progress of the disease and in response to treatment
89. Transsphenoidal surgery for acromegaly: long term results in 50 patients
90. The spectrum of thyroid disease in a community: the Whickham Study
91. Pituitary syndromes
92. Pituitary apoplexy: its incidence and clinical significance
93. An assessment of glucose intolerance in acromegaly and its response to medical treatment
94. Changes in circulating somatomedin‐C levels in bromocriptine treated acromegaly
95. Recurrence of acromegaly after pituitary apoplexy
96. The treatment of acromegaly with special reference to transsphenoidal hypophysectomy
97. Serum growth hormone levels and size of pituitary tumour in untreated acromegaly
98. Mortality in acromegaly